Endothelial derived vasoactive factors and leukocyte derived inflammatory mediators in subjects with asymptomatic atherosclerosis

被引:18
作者
Anwaar, I [1 ]
Gottsäter, A
Hedblad, B
Palmqvist, B
Mattiasson, I
Lindgärde, F
机构
[1] Univ Lund Hosp, Dept Med, Wallenberg Lab, S-20502 Malmo, Sweden
[2] Univ Lund Hosp, Dept Vasc & Renal Dis, S-20502 Malmo, Sweden
关键词
D O I
10.1177/000331979804901201
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
To clarify relationships between the (endothelial vasodilatory and vasoconstrictive function) and leukocyte inflammatory mediators in subjects with asymptomatic atherosclerosis, we measured (intraplatelet cyclic 3-5C guanosine monophosphate [cGMP] and cyclic 3-5C adenosine monophosphate [cAMP]), plasma endothelin (ET-1), and plasma neopterin in 197 subjects with asymptomatic atherosclerosis (median age 63 years, range 49-69 years). We measured neutrophil protease 4 (NP4), tumor necrosis factor (TNF mu), soluble tumor necrosis factor receptor-1 (sTNFR-1), and neutrophil gelatinase associated lipocalin (NGAL) in 152 of the 197 subjects. Intraplatelet cGMP correlated inversely with plasma ET-1 (r=-0.22; p=0.01), which confirms earlier in vitro data of the inhibitory effect of ET-1 on NO production and/or the cGMP mediated inhibitory effect of NO on ET-1 production. Plasma neopterin as well as NP4 correlated directly with intraplatelet cGMP (r=0.24; p<0.01 and r=0.33; p<0.001, respectively). Intraplatelet cAMP correlated directly with plasma TNF mu (r=0.17; p<0.05) and sTNFR-1 (r=0.20; p<0.05). The relationship between leukocyte derived inflammatory mediators and intraplatelet cyclic nucleotides suggest an antiaggregating effect of leukocytes upon platelets, which may constitute a negative feedback mechanism that inhibits platelet activation during the atherosclerotic inflammatofy process.
引用
收藏
页码:957 / 966
页数:10
相关论文
共 61 条
  • [1] AGGARWAL BB, 1985, J BIOL CHEM, V260, P2345
  • [2] THE EFFECT OF CHOLESTEROL-LOWERING AND ANTIOXIDANT THERAPY ON ENDOTHELIUM-DEPENDENT CORONARY VASOMOTION
    ANDERSON, TJ
    MEREDITH, IT
    YEUNG, AC
    FREI, B
    SELWYN, AP
    GANZ, P
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (08) : 488 - 493
  • [3] Anwaar I, 1996, INT ANGIOL, V15, P201
  • [4] STUDIES OF THE RELEASE AND TURNOVER OF A HUMAN NEUTROPHIL LIPOCALIN
    AXELSSON, L
    BERGENFELDT, M
    OHLSSON, K
    [J]. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1995, 55 (07) : 577 - 588
  • [5] BATTISTINI B, 1993, LAB INVEST, V68, P600
  • [6] Belch Jill J. F., 1994, Current Opinion in Lipidology, V5, P440, DOI 10.1097/00041433-199412000-00007
  • [7] DESIGN AND FEASIBILITY
    BERGLUND, G
    ELMSTAHL, S
    JANZON, L
    LARSSON, SA
    [J]. JOURNAL OF INTERNAL MEDICINE, 1993, 233 (01) : 45 - 51
  • [8] RELEASE OF ENDOTHELIN FROM THE PORCINE AORTA - INHIBITION BY ENDOTHELIUM-DERIVED NITRIC-OXIDE
    BOULANGER, C
    LUSCHER, TF
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (02) : 587 - 590
  • [9] BROOKER G, 1979, ADV CYCLIC NUCLEOTID, P1
  • [10] EVIDENCE FOR ALTERED PLATELET NITRIC-OXIDE SYNTHESIS IN ESSENTIAL-HYPERTENSION
    CADWGAN, TM
    BENJAMIN, N
    [J]. JOURNAL OF HYPERTENSION, 1993, 11 (04) : 417 - 420